03.22.2016 But evidence for causality remains weak by Parker Brown Staff Writer, MedPage Today Endocrine-disrupting chemicals could be costing the European Union up to €1.5 billion ($1.6 billion) a year because of female reproductive health problems, a new report estimated. Researchers looked at two conditions that they said had the most robust data: uterine fibroids […]
The Lancet Volume 13, No. 3, p330–338, March 2014 Dr Philippe Grandjean, MD Summary Neurodevelopmental disabilities, including autism, attention-deficit hyperactivity disorder, dyslexia, and other cognitive impairments, affect millions of children worldwide, and some diagnoses seem to be increasing in frequency. Industrial chemicals that injure the developing brain are among the known causes for this rise […]